"10.1371_journal.pone.0089428","plos one","2014-02-24T00:00:00Z","Itziar Montalvo; Alfonso Guti√©rrez-Zotes; Marta Creus; Rosa Monseny; Laura Ortega; Joan Franch; Stephen M Lawrie; Rebecca M Reynolds; Elisabet Vilella; Javier Labad","Early Psychosis Program and Research Department, Hospital Universitari Institut Pere Mata, IISPV, Universitat Rovira i Virgili, CIBERSAM, Reus, Spain; Division of Psychiatry, Kennedy Tower, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, United Kingdom; Endocrinology Unit, University/BHF Centre for Cardiovascular Sciences, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom","Conceived and designed the experiments: JL AGZ RMR SML. Performed the experiments: IM MC JF LO RM. Analyzed the data: JL IM. Contributed reagents/materials/analysis tools: RMR EV. Wrote the paper: IM RMR EV JL.","SML has received financial support from Pfizer (formerly Wyeth) in relation to imaging studies of people with schizophrenia and bipolar disorder. SML has done consultancy work for Roche Pharmaceuticals in connection with a possible new treatment for schizophrenia. SML has also received honoraria for lectures, chairing meetings, and consultancy work from Janssen in connection with brain imaging and therapeutic initiatives for psychosis. JL has received honoraria for lectures from Janssen. IM, AGZ, MC, LO, RM, JF, EV and RMR have no biomedical financial interests or potential conflicts of interest. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Itziar Montalvo","IM",10,TRUE,4,5,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
